Pneumococcal conjugate second or third-dose vaccines (PCVc) in Cambodia
Cambodia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 80.0% in 2025. ◆ Volatile
Latest (2025)
80.0%
Change on year
down 3.6%
World rank
118th
of 194 countries
All-time high
88.0%
in 2019
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Cambodia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Cambodia stood at 80.0%.
The figure is down 3.6% on the previous year and up 17.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Cambodia peaked at 88.0% in 2019 and was at its lowest, 0.0%, in 2008.
Cambodia ranks 118th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Cambodia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 68.0% | — |
| 2016 | 87.0% | +27.9% |
| 2017 | 81.0% | -6.9% |
| 2018 | 83.0% | +2.5% |
| 2019 | 88.0% | +6.0% |
| 2020 | 86.0% | -2.3% |
| 2021 | 86.0% | +0.0% |
| 2022 | 84.0% | -2.3% |
| 2023 | 82.0% | -2.4% |
| 2024 | 83.0% | +1.2% |
| 2025 | 80.0% | -3.6% |
Cambodia compared with similar countries
- Cambodia's 80.0% is below the median for lower middle income countries, which is 84.0%, 95% of the median. (47 countries reporting)
- Cambodia's 80.0% is below the median for East Asia & Pacific, which is 81.0%, 99% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 40.7% | 0.0% | 88.0% | 10 |
| 2020s | 83.5% | 80.0% | 86.0% | 6 |
Countries ranked near Cambodia
More health data for Cambodia
- Un projection of annual infant deaths, annual growth rate -1.78 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.572 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,125 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,047 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate -1.05 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0488 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.05 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Cambodia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Cambodia was 80.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Cambodia?
- The highest recorded value was 88.0% in 2019.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Cambodia?
- The lowest recorded value was 0.0% in 2008.
- How does Cambodia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cambodia ranks 118th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Cambodia?
- Over the last ten years it is up 17.6%. The long-run trend across the full record is volatile.
- Where does this Cambodia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).